New Diagnostic Tools Show Promise for Pediatric Sepsis
Researchers validate blood tests and alert systems to help identify sepsis in critically ill children.
Updated on Oct. 16, 2026 in Children’s Health
Live Poll
Should hospitals replace standard sepsis alerts with new rapid blood tests to improve patient screening?
Two recent studies highlight tools for identifying pediatric sepsis, including a validation of the SeptiCyte RAPID blood test and an evaluation of a computerized early detection model. These findings help illustrate the ongoing challenge of distinguishing life-threatening infections from noninfectious inflammation in emergency settings.
Why it matters
Distinguishing sepsis from noninfectious inflammation is a complex and time-sensitive clinical hurdle in pediatric care. Better diagnostic tools could eventually improve how hospitals approach early treatment decisions for critically ill children.
A study evaluated 166,943 pediatric encounters for sepsis detection, while a separate validation study examined the accuracy of the SeptiCyte RAPID molecular test. Preliminary results show the test achieved an area under the curve of 0.83 in distinguishing sepsis from noninfectious inflammation.
The players
Immunexpress
A molecular diagnostics company that develops blood-based tests to identify sepsis and immune responses.
The details
The SeptiCyte RAPID platform uses a cartridge-based molecular system to analyze a 250uL whole blood sample, generating a SeptiScore from 0 to 15 to predict sepsis likelihood within about one hour. Researchers found that integrating six routine laboratory tests with the platform improved the diagnostic area under the curve to 0.87. Separately, the Epic Pediatric Sepsis Early Detection Model monitors clinical indicators in emergency departments to alert staff, though its current positive predictive value stands at 3 percent.
Timeline
January 2024 through June 2025: Period covered by the JAMA Pediatrics retrospective study.
September 1, 2026: Publication date of the SeptiCyte RAPID validation study.
Early October 2026: Publication date of the JAMA Pediatrics sepsis alert study.
October 15, 2026: Immunexpress announced the results of the validation study.
Health Landscape
The Epic Pediatric Sepsis Early Detection Model is used by hospitals to track infection risk, and these new validation findings extend the current landscape of diagnostic tools available to clinicians. Integrating molecular diagnostics with existing electronic alerts marks a shift in how systems aim to improve sepsis detection accuracy.
These diagnostic developments highlight the importance of timely assessment when a child shows signs of critical illness in an emergency setting. Parents should continue to discuss symptom progression and infection concerns with their pediatrician or emergency care team.
The takeaway
Rapid identification of sepsis remains a critical priority for pediatric emergency medicine. Parents should prioritize seeking immediate medical evaluation if they notice signs of severe illness in their child, as early intervention is essential for better outcomes.
Further reading
For more on managing pediatric conditions, visit our Children’s Health section.
More information
For additional context, visit the Immunexpress molecular diagnostics company information page.
Source note: This article includes information reported by Startup Fortune.
Live Poll
Should hospitals replace standard sepsis alerts with new rapid blood tests to improve patient screening?
